Kinaxis (TSE:KXS) Given New C$215.00 Price Target at ATB Capital

Kinaxis (TSE:KXSGet Free Report) had its target price increased by research analysts at ATB Capital from C$205.00 to C$215.00 in a research note issued to investors on Friday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. ATB Capital’s target price would indicate a potential upside of 28.87% from the stock’s previous close.

A number of other brokerages also recently issued reports on KXS. TD Securities decreased their price objective on Kinaxis from C$195.00 to C$190.00 and set a “buy” rating on the stock in a research report on Friday. Stifel Nicolaus decreased their price objective on Kinaxis from C$210.00 to C$195.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd. Finally, Scotiabank decreased their price objective on Kinaxis from C$200.00 to C$190.00 in a research report on Thursday, August 29th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of C$192.67.

View Our Latest Research Report on KXS

Kinaxis Price Performance

Kinaxis stock traded up C$12.19 during midday trading on Friday, reaching C$166.83. 85,017 shares of the stock traded hands, compared to its average volume of 66,671. The stock’s fifty day moving average is C$154.96 and its 200-day moving average is C$154.21. Kinaxis has a 12 month low of C$132.93 and a 12 month high of C$172.83. The stock has a market cap of C$4.71 billion, a P/E ratio of 166.83, a PEG ratio of 3.60 and a beta of 0.78. The company has a quick ratio of 2.29, a current ratio of 1.90 and a debt-to-equity ratio of 12.40.

Kinaxis (TSE:KXSGet Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported C$0.47 EPS for the quarter, beating analysts’ consensus estimates of C$0.43 by C$0.04. Kinaxis had a return on equity of 4.87% and a net margin of 4.59%. The company had revenue of C$165.79 million during the quarter, compared to analyst estimates of C$170.56 million. As a group, equities research analysts anticipate that Kinaxis will post 4.2526231 EPS for the current year.

Insider Transactions at Kinaxis

In other news, Senior Officer Andrew William Robert Bell sold 701 shares of the stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of C$149.56, for a total value of C$104,841.70. Following the sale, the insider now directly owns 831 shares in the company, valued at approximately C$124,284.53. This represents a 0.00 % decrease in their ownership of the stock. In other news, Director Angel Luis Mendez purchased 1,400 shares of the company’s stock in a transaction on Friday, September 6th. The shares were acquired at an average price of C$148.96 per share, for a total transaction of C$208,537.00. Also, Senior Officer Andrew William Robert Bell sold 701 shares of the business’s stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of C$149.56, for a total value of C$104,841.70. Following the completion of the transaction, the insider now directly owns 831 shares of the company’s stock, valued at approximately C$124,284.53. This trade represents a 0.00 % decrease in their position. Over the last three months, insiders have sold 8,265 shares of company stock worth $1,268,146. 1.20% of the stock is currently owned by company insiders.

Kinaxis Company Profile

(Get Free Report)

Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.

Featured Articles

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.